(19)
(11) EP 4 739 295 A1

(12)

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 24740405.6

(22) Date of filing: 05.07.2024
(51) International Patent Classification (IPC): 
A61K 31/137(2006.01)
A61K 45/06(2006.01)
A61K 9/00(2006.01)
A61K 31/56(2006.01)
A61P 11/06(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/137; A61K 31/56; A61P 11/06; A61K 9/0075; A61K 45/06
 
C-Sets:
  1. A61K 31/137, A61K 2300/00;
  2. A61K 31/56, A61K 2300/00;

(86) International application number:
PCT/EP2024/068986
(87) International publication number:
WO 2025/012115 (16.01.2025 Gazette 2025/03)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 07.07.2023 US 202363525601 P
20.07.2023 EP 23186744

(71) Applicant: Norton (Waterford) Limited
Waterford, X91 WK68 (IE)

(72) Inventors:
  • SMALL, Calvin J.
    Cork Road Waterford, X91 WK68 (IE)
  • EDELSON, Jeffrey
    Cork Road Waterford, X91 WK68 (IE)
  • KROPOTOVA, Alexandra
    Cork Road Waterford, X91 WK68 (IE)
  • STOYANOV, Stanislav
    Cork Road Waterford, X91 WK68 (IE)

(74) Representative: Elkington and Fife LLP 
Prospect House 8 Pembroke Road
Sevenoaks, Kent TN13 1XR
Sevenoaks, Kent TN13 1XR (GB)

   


(54) AN INHALABLE FORMULATION OF FLUTICASONE PROPIONATE AND ALBUTEROL SULFATE FOR THE TREATMENT OF ASTHMA